|
|
|
From Bench to Bedside
With expertise in oncology-based preclinical drug development, genomics, and clinical trial design, TD2 delivers comprehensive drug development services within an organizational culture of successful collaboration:
- Target validation and characterization of mechanism of action and molecular markers
- Design of clinically relevant animal models that offer more precise analogs of human disease states
- In vitro and in vivo testing strategies to evaluate compounds in combination with experimental and FDA-approved treatments
- Alliances with world-class clinical institutions such as Virginia G. Piper Cancer Center, US Oncology, Arizona Cancer Center, Banner Health, Barrow Neurological Institute, MD Anderson Cancer Center, Moffitt Cancer Center and Research Institute, and the Mayo Clinic
|
|
|
|
